Description
Torseheal (Torsemide) 10 mg
Torseheal 10 mg is a torsemide tablet. Torsemide is a loop diuretic medicine used to help remove excess fluid from the body and to reduce swelling caused by certain medical conditions.
Active Ingredient and Medicine Class
The verified active ingredient is torsemide, a loop diuretic. Medicines in this class act on the kidneys to increase urine production and reduce salt and water retention.
Established Medical Uses
Official prescribing information for torsemide tablets lists use in the treatment of edema associated with heart failure, renal disease, or hepatic disease, and also for hypertension in approved products. The exact approved indications can vary by country and product label.
How It Works
Torsemide works in the kidney by blocking salt reabsorption in the loop of Henle. This reduces the body’s retention of sodium and water, leading to increased urine output and a decrease in fluid overload.
Important Safety Information
Torsemide is contraindicated in patients with anuria and in those with a history of hypersensitivity to torsemide or sulfonylureas. Important precautions include the risk of excessive fluid loss, low blood pressure, and electrolyte disturbances such as low potassium or low sodium. Torsemide may interact with other medicines that affect blood pressure, kidney function, or electrolyte balance, and the label notes potential interaction with sensitive CYP2C9 substrates such as warfarin and phenytoin.
Possible Side Effects
Common adverse effects include increased urination, dizziness, headache, weakness, and changes in blood electrolytes. More serious reactions can include dehydration, hypotension, worsening kidney function, and significant electrolyte abnormalities. As with other sulfonamide-derived medicines, hypersensitivity reactions may occur in susceptible patients.
Scientific Evidence
Clinical studies and reviews in heart failure have found that torsemide is an effective loop diuretic for reducing edema and improving diuresis. Some comparative studies versus furosemide suggest possible advantages in certain short-term measures, while larger reviews have not shown consistent superiority for major outcomes such as mortality. Overall, the evidence supports torsemide as a clinically established diuretic, with outcome advantages versus other loop diuretics remaining uncertain.
Medical Information Notice
This summary is provided for educational purposes only and is based on sources available at the time of review. It does not replace the official patient leaflet, prescribing information, or assessment by a qualified healthcare professional.
Medical Sources
- DailyMed / FDA label: TORSEMIDE tablet, prescribing information
- Torsemide Investigators Group. Oral torsemide in patients with chronic congestive heart failure: effects on body weight, edema, and electrolyte excretion. PubMed, 1994. PubMed article
